Search hospitals
>
Quebec
>
GREENFIELD PARK
CISSS de la Monteregie-Centre
Claim this profile
GREENFIELD PARK, Quebec J4V 2H1
Global Leader in Lung Cancer
Global Leader in Parkinson's disease
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Crohn's Disease
Conducts research for Prostate Cancer
36 reported clinical trials
2 medical researchers
Summary
CISSS de la Monteregie-Centre is a medical facility located in GREENFIELD PARK, Quebec. This center is recognized for care of Lung Cancer, Parkinson's disease, Non-Small Cell Lung Cancer, Crohn's Disease, Prostate Cancer and other specialties. CISSS de la Monteregie-Centre is involved with conducting 36 clinical trials across 46 conditions. There are 2 research doctors associated with this hospital, such as Etienne Desilets and Pierre Desjardins.
Area of expertise
Lung Cancer
CISSS de la Monteregie-Centre has run 12 trials for Lung Cancer. Some of their research focus areas include:
Parkinson's Disease
CISSS de la Monteregie-Centre has run 11 trials for Parkinson's disease. Some of their research focus areas include:
Top PIs
Etienne Desilets
CISSS de la Monteregie-Centre
7 years of reported clinical research
Pierre Desjardins
Hopital Charles-LeMoyne
5 years of reported clinical research
Clinical Trials running at CISSS de la Monteregie-Centre
Prostate Cancer
Lung Cancer
Multiple Myeloma
Chronic Lymphocytic Leukemia
Cancer
Non-Small Cell Lung Cancer
Breast Cancer
Relapse
Lymphoma
Small Cell Lymphoma
Opevesostat
for Prostate Cancer
This is a phase 3, randomized, open-label study of opevesostat compared to alternative abiraterone acetate or enzalutamide in participants with metastatic castration-resistant prostate cancer (mCRPC) with respect to overall survival (OS) in participants with mCRPC previously treated with next-generation hormonal agent (NHA) and taxane-based chemotherapy. It is hypothesized that opevesostat is superior with respect to OS in androgen receptor ligand binding domain (AR LBD) mutation-negative and -positive participants.
Recruiting
2 awards
Phase 3
10 criteria
Mevrometostat + Enzalutamide
for Prostate Cancer
This study will explore whether a combination of the investigational drug mevrometostat (PF-06821497) and enzalutamide will work better than taking enzalutamide alone in participants with mCSPC who are ARPI naïve and have not yet received chemotherapy in the mCSPC setting.
Recruiting
1 award
Phase 3
4 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at CISSS de la Monteregie-Centre?
CISSS de la Monteregie-Centre is a medical facility located in GREENFIELD PARK, Quebec. This center is recognized for care of Lung Cancer, Parkinson's disease, Non-Small Cell Lung Cancer, Crohn's Disease, Prostate Cancer and other specialties. CISSS de la Monteregie-Centre is involved with conducting 36 clinical trials across 46 conditions. There are 2 research doctors associated with this hospital, such as Etienne Desilets and Pierre Desjardins.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.